Advanced search
Publication Cover
Acta Oncologica Volume 47, 2008 - Issue 4
Journal homepage
2,315
Views
16
CrossRef citations to date
0
Altmetric
Original Article

Tamoxifen for one year versus two years versus 6 months of Tamoxifen and 6 months of megestrol acetate: A randomized comparison in postmenopausal patients with high-risk breast cancer (DBCG 89C)

Jørn Andersen Department of Oncology, Århus University Hospital, Århus Sygehus, DenmarkCorrespondence[email protected].
,
Claus Kamby Department of Oncology, Herlev University Hospital, Herlev, Denmark
,
Bent Ejlertsen Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
,
Søren Cold Department of Oncology, Odense University Hospital, Odense, Denmark
,
Marianne Ewertz Department of Oncology, Aalborg University Hospital, Aalborg, Denmark
,
Erik H. Jacobsen Department of Oncology, Vejle Hospital, Vejle, Denmark
,
Preben Philip Department of Oncology, Næstved Hospital, Næstved, Denmark
,
Knud A. Møller Department of Oncology, Herning Hospital, Herning, Denmark
,
Disa Jensen DBCG Registry, Copenhagen, Denmark
&
Susanne Møller DBCG Registry, Copenhagen, Denmark
 show all
Pages 718-724 | Received 30 Dec 2007, Published online: 08 Jul 2009

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Bent Ejlertsen, Birgitte Vrou Offersen, Jens Overgaard, Peer Christiansen, Maj-Britt Jensen, Niels Kroman, Ann Søgaard Knoop & Henning Mouridsen. (2018) Forty years of landmark trials undertaken by the Danish Breast Cancer Cooperative Group (DBCG) nationwide or in international collaboration. Acta Oncologica 57:1, pages 3-12.
Read now
Maddalena Barba, Laura Pizzuti, Domenico Sergi, Marcello Maugeri-Saccà, Cristina Vincenzoni, Francesca Conti, Federica Tomao, Enrico Vizza, Luigi Di Lauro, Franco Di Filippo, Silvia Carpano, Luciano Mariani & Patrizia Vici. (2014) Hot flushes in women with breast cancer: state of the art and future perspectives. Expert Review of Anticancer Therapy 14:2, pages 185-198.
Read now
Per Eystein Lønning. (2009) Additive endocrine therapy for advanced breast cancer – back to the future. Acta Oncologica 48:8, pages 1092-1101.
Read now
Susanne Møller, Maj-Britt Jensen, Bent Ejlertsen, Karsten D. Bjerre, Martin Larsen, Hanne B. Hansen, Peer Christiansen & Henning T. Mouridsen. (2008) The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise. Acta Oncologica 47:4, pages 506-524.
Read now
Marianne Ewertz, Mette Moe Kempel, Maria Düring, Maj-Britt Jensen, Michael Andersson, Peer Christiansen, Niels Kroman, Birgitte Bruun Rasmussen & Marie Overgaard. (2008) Breast conserving treatment in Denmark, 1989–1998. A nationwide population-based study of the Danish Breast Cancer Co-operative Group.. Acta Oncologica 47:4, pages 682-690.
Read now

Articles from other publishers (11)

Ciro Comparetto & Franco Borruto. (2023) Treatments and Management of Menopausal Symptoms: Current Status and Future Challenges. OBM Geriatrics 07:03, pages 1-47.
Crossref
Sanne Løkkegaard, Daniel Elias, Carla L. Alves, Martin V. Bennetzen, Anne-Vibeke Lænkholm, Martin Bak, Morten F. Gjerstorff, Lene E. Johansen, Henriette Vever, Christina Bjerre, Tove Kirkegaard, Bo Nordenskjöld, Tommy Fornander, Olle Stål, Linda S. Lindström, Laura J. Esserman, Anne E. Lykkesfeldt, Jens S. Andersen, Rikke Leth-Larsen & Henrik J. Ditzel. (2021) MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit. npj Breast Cancer 7:1.
Crossref
Elgene Lim, Gerard Tarulli, Neil Portman, Theresa E Hickey, Wayne D Tilley & Carlo Palmieri. (2016) Pushing estrogen receptor around in breast cancer. Endocrine-Related Cancer 23:12, pages T227-T241.
Crossref
Reiner Hoppe, Joanna Achinger-Kawecka, Stefan Winter, Peter Fritz, Wing-Yee Lo, Werner Schroth & Hiltrud Brauch. (2013) Increased expression of miR-126 and miR-10a predict prolonged relapse-free time of primary oestrogen receptor-positive breast cancer following tamoxifen treatment. European Journal of Cancer 49:17, pages 3598-3608.
Crossref
Javaid Iqbal, Ophira M. Ginsburg, Thiwanka D. Wijeratne, Anthony Howell, Gareth Evans, Ivana Sestak & Steven A. Narod. (2012) Endometrial cancer and venous thromboembolism in women under age 50 who take tamoxifen for prevention of breast cancer: A systematic review. Cancer Treatment Reviews 38:4, pages 318-328.
Crossref
Maria B. Lyng, Anne-Vibeke Lænkholm, Rolf Søkilde, Karina H. Gravgaard, Thomas Litman & Henrik J. Ditzel. (2012) Global MicroRNA Expression Profiling of High-Risk ER+ Breast Cancers from Patients Receiving Adjuvant Tamoxifen Mono-Therapy: A DBCG Study. PLoS ONE 7:5, pages e36170.
Crossref
Zhi-Hua Liu, Yan-Lei Ma, Yan-Ping He, Peng Zhang, Yu-Kun Zhou & Huanlong Qin. (2010) Tamoxifen reverses the multi-drug-resistance of an established human cholangiocarcinoma cell line in combined chemotherapeutics. Molecular Biology Reports 38:3, pages 1769-1775.
Crossref
S. SAMUEL KIM, JUNG RYEOL LEE, BYUNG CHUL JEE, CHANG SUK SUH, SEOK HYUN KIM, ALISON TING & BRIAN PETROFF. (2010) Use of Hormonal Protection for Chemotherapy-induced Gonadotoxicity. Clinical Obstetrics & Gynecology 53:4, pages 740-752.
Crossref
Zhi-Hua Liu, Yan-Ping He & Huanlong Qin. (2009) The growth-inhibition effect of tamoxifen in the combination chemotherapeutics on the human cholangiocarcinoma cell line QBC939. Molecular Biology Reports 37:6, pages 2693-2701.
Crossref
Bent EjlertsenMaj-Britt JensenKirsten V. NielsenEva BalslevBirgitte B. RasmussenGro L. WillemoePernille B. HertelAnn S. KnoopHenning T. MouridsenNils Brünner. (2010) HER2, TOP2A , and TIMP-1 and Responsiveness to Adjuvant Anthracycline-Containing Chemotherapy in High-Risk Breast Cancer Patients . Journal of Clinical Oncology 28:6, pages 984-990.
Crossref
Michelle P Warren. (2008) Is megestrol acetate a suitable option for treatment of hot flashes in women with breast cancer?. Nature Clinical Practice Endocrinology & Metabolism 4:12, pages 650-651.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.